136 related articles for article (PubMed ID: 26936759)
21. Evidence for gene expression by unintegrated human immunodeficiency virus type 1 DNA species.
Brussel A; Sonigo P
J Virol; 2004 Oct; 78(20):11263-71. PubMed ID: 15452245
[TBL] [Abstract][Full Text] [Related]
22. Low-level detection and quantitation of cellular HIV-1 DNA and 2-LTR circles using droplet digital PCR.
Henrich TJ; Gallien S; Li JZ; Pereyra F; Kuritzkes DR
J Virol Methods; 2012 Dec; 186(1-2):68-72. PubMed ID: 22974526
[TBL] [Abstract][Full Text] [Related]
23. Longitudinal monitoring of 2-long terminal repeat circles in peripheral blood mononuclear cells from patients with chronic HIV-1 infection.
Brussel A; Mathez D; Broche-Pierre S; Lancar R; Calvez T; Sonigo P; Leibowitch J
AIDS; 2003 Mar; 17(5):645-52. PubMed ID: 12646786
[TBL] [Abstract][Full Text] [Related]
24. Human immunodeficiency virus type 1-infected persons with residual disease and virus reservoirs on suppressive highly active antiretroviral therapy can be stratified into relevant virologic and immunologic subgroups.
Dornadula G; Nunnari G; Vanella M; Roman J; Babinchak T; DeSimone J; Stern J; Braffman M; Zhang H; Pomerantz RJ
J Infect Dis; 2001 Jun; 183(11):1682-7. PubMed ID: 11343220
[TBL] [Abstract][Full Text] [Related]
25. Development of methods for coordinate measurement of total cell-associated and integrated human immunodeficiency virus type 1 (HIV-1) DNA forms in routine clinical samples: levels are not associated with clinical parameters, but low levels of integrated HIV-1 DNA may be prognostic for continued successful therapy.
Carr JM; Cheney KM; Coolen C; Davis A; Shaw D; Ferguson W; Chang G; Higgins G; Burrell C; Li P
J Clin Microbiol; 2007 Apr; 45(4):1288-97. PubMed ID: 17314225
[TBL] [Abstract][Full Text] [Related]
26. Effect of raltegravir on the total and unintegrated proviral HIV DNA during raltegravir-based HAART.
Nicastri E; Tommasi C; Abbate I; Bonora S; Tempestilli M; Bellagamba R; Viscione M; Rozera G; Gallo AL; Ivanovic J; Amendola A; Pucillo L; Di Perri G; Capobianchi MR; Narciso P
Antivir Ther; 2011; 16(6):797-803. PubMed ID: 21900711
[TBL] [Abstract][Full Text] [Related]
27. HIV-1 and HIV-2 produce different amounts of 2-long terminal repeat circular DNA in vitro.
Gueudin M; Braun J; Plantier JC; Simon F
AIDS; 2008 Nov; 22(18):2543-5. PubMed ID: 19005280
[TBL] [Abstract][Full Text] [Related]
28. HIV-1 DNA burden in peripheral blood CD4+ cells influences disease progression, antiretroviral efficacy, and CD4+ T-cell restoration.
Russell RR; Bowmer MI; Nguyen C; Grant MD
Viral Immunol; 2001; 14(4):379-89. PubMed ID: 11792067
[TBL] [Abstract][Full Text] [Related]
29. Human Immunodeficiency Virus type 1 in seronegative infants born to HIV-1-infected mothers.
Vázquez Pérez JA; Basualdo Sigales MC; Reyes-Terán G; Gudiño Rosales JC; Soler Claudín C
Virol J; 2006 Jun; 3():52. PubMed ID: 16808849
[TBL] [Abstract][Full Text] [Related]
30. Quantification of proviral DNA load of human immunodeficiency virus type 2 subtypes A and B using real-time PCR.
Gueudin M; Damond F; Simon F
Methods Mol Biol; 2005; 304():215-20. PubMed ID: 16061978
[TBL] [Abstract][Full Text] [Related]
31. Circular viral DNA detection and junction sequence analysis from PBMC of SHIV-infected cynomolgus monkeys with undetectable virus plasma RNA.
Cara A; Maggiorella MT; Bona R; Sernicola L; Baroncelli S; Negri DR; Leone P; Fagrouch Z; Heeney J; Titti F; Cafaro A; Ensoli B
Virology; 2004 Jul; 324(2):531-9. PubMed ID: 15207638
[TBL] [Abstract][Full Text] [Related]
32. PCR-based detection is unable to consistently distinguish HIV 1LTR circles.
Yoder KE; Fishel R
J Virol Methods; 2006 Dec; 138(1-2):201-6. PubMed ID: 16956673
[TBL] [Abstract][Full Text] [Related]
33. Analysis of early human immunodeficiency virus type 1 DNA synthesis by use of a new sensitive assay for quantifying integrated provirus.
Brussel A; Sonigo P
J Virol; 2003 Sep; 77(18):10119-24. PubMed ID: 12941923
[TBL] [Abstract][Full Text] [Related]
34. Two long terminal repeat circles and persistent HIV-1 replication.
Sharkey ME; Stevenson M
Curr Opin Infect Dis; 2001 Feb; 14(1):5-11. PubMed ID: 11979108
[TBL] [Abstract][Full Text] [Related]
35. Differences in proviral DNA load between HIV-1- and HIV-2-infected patients.
Gueudin M; Damond F; Braun J; Taïeb A; Lemée V; Plantier JC; Chêne G; Matheron S; Brun-Vézinet F; Simon F
AIDS; 2008 Jan; 22(2):211-5. PubMed ID: 18097223
[TBL] [Abstract][Full Text] [Related]
36. 2-LTR circular viral DNA as a marker for human immunodeficiency virus type 1 infection in vivo.
Pauza CD; Trivedi P; McKechnie TS; Richman DD; Graziano FM
Virology; 1994 Dec; 205(2):470-8. PubMed ID: 7975248
[TBL] [Abstract][Full Text] [Related]
37. Identification of two mutually exclusive groups after long-term monitoring of HIV DNA 2-LTR circle copy number in patients on HAART.
Morlese J; Teo IA; Choi JW; Gazzard B; Shaunak S
AIDS; 2003 Mar; 17(5):679-83. PubMed ID: 12646790
[TBL] [Abstract][Full Text] [Related]
38. Impact of raltegravir on HIV-1 RNA and DNA forms following initiation of antiretroviral therapy in treatment-naive patients.
Stephan C; Baldauf HM; Barry J; Giordano FA; Bartholomae CC; Haberl A; Bickel M; Schmidt M; Laufs S; Kaderali L; Keppler OT
J Antimicrob Chemother; 2014 Oct; 69(10):2809-18. PubMed ID: 24962031
[TBL] [Abstract][Full Text] [Related]
39. Cell-Associated HIV-1 DNA and RNA Decay Dynamics During Early Combination Antiretroviral Therapy in HIV-1-Infected Infants.
Uprety P; Chadwick EG; Rainwater-Lovett K; Ziemniak C; Luzuriaga K; Capparelli EV; Yenokyan G; Persaud D
Clin Infect Dis; 2015 Dec; 61(12):1862-70. PubMed ID: 26270687
[TBL] [Abstract][Full Text] [Related]
40. The regulation of HIV-1 gene expression: the emerging role of chromatin.
He G; Ylisastigui L; Margolis DM
DNA Cell Biol; 2002 Oct; 21(10):697-705. PubMed ID: 12443539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
